Home Product Cefoperazone and Tazobactam Injection

Cefoperazone and Tazobactam Injection

This formulation consists of:

Active Ingredients:
- Cefoperazone
- Tazobactam
Pharmacological Grade Solvents and Excipients

Benefits:

Broad-spectrum antibiotic that targets a wide range of both Gram-positive and Gram-negative bacteria
Tazobactam enhances the efficacy of cefoperazone
Treats multi-drug resistant infections, including those caused by hospital-acquired pathogens
Effective against serious infections such as pneumonia, sepsis, intra-abdominal infections and urinary tract infections
Reduces the risk of bacterial resistance when used in combination with tazobactam

Available Variations in formulations:

We offer Cefoperazone and Tazobactam Injection in the following strengths:

562.5mg
1125mg

Description
Additional information

Get In Touch

Product Details

Cefoperazone and Tazobactam Injection is a combination of cefoperazone, a cephalosporin antibiotic, and tazobactam, a beta-lactamase inhibitor. This combination enhances the antimicrobial spectrum of cefoperazone by inhibiting the beta-lactamase enzymes produced by resistant bacteria. It is highly effective against both Gram-positive and Gram-negative bacteria, including many that are resistant to other antibiotics. This makes it especially useful for treating complex, hospital-acquired infections, including those caused by resistant pathogens.

Indications

Effective in treating complicated urinary tract infections (cUTIs)
Management of intra-abdominal infections such as peritonitis, cholecystitis, and abscesses
Treatment of bacterial pneumonia, particularly in hospitalized patients and those on ventilators (VAP)
Complicated Skin and Soft Tissue Infections (cSSTIs): Serious skin and soft tissue infections caused by susceptible Gram-positive and Gram-negative bacteria
Effective in treating bacteremia and Sepsis
Effective in managing infections in immunocompromised patients, particularly those with neutropenia
Useful in preventing or treating infections following surgery, particularly in high-risk patients

Dosage

Adults: Dosage is determined based on infection type and severity.
Pediatric Patients: The appropriate pediatric dose should be determined by a healthcare provider based on weight and the type of infection.

Uses

N/A

Side Effects

N/A

Packaging Volume

Vial Pack + WFI

Minimum Order Quantity

15,000 Units

Delivery Time

45–60 Business Days

Top Categories

Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.